Micron Waste Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three Months Ended March 31, 2020 and 2019

- July 29th, 2020

As a result of a review by the British Columbia Securities Commission (the “BCSC”), we are issuing the following press release to clarify our disclosure.

As a result of a review by the British Columbia Securities Commission (the “BCSC”), we are issuing the following press release to clarify our disclosure.

Micron Waste Technologies Inc. (“Micron” or the “Company”) (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2, OTCQB “MICWF”) announced it has amended and restated its interim financial statements (the “Interim Financial Statements”) and interim management’s discussion and analysis (the “MD&A”) for the three months ended March 31, 2020 and 2019. Among other items, the amended and restated Interim
Financial Statements and MD&A were filed to:

• clarify the Company’s disclosure with regard to Covid Technologies Inc.;
• provide additional disclosure regarding the Company’s related party transactions; and
• include disclosure regarding assumptions relied upon to develop forward looking information.

The amended and restated Interim Financial Statements and MD&A for the indicated period are available under the Company’s profile on SEDAR at www.sedar.com.

ON BEHALF OF THE BOARD OF DIRECTORS
“Kal Malhi”

Kal Malhi,
Chairman

For further information, please contact Kal Malhi at 604-805-4602 or kal@bullruncapital.ca.

FORWARD LOOKING STATEMENTS:

The forward-looking information contained in this press release is made as of the date of this press release and, except as required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking information, whether as a result of new information, future events or otherwise, except as may be required by law. By its very nature, such forwardlooking information requires the Company to make assumptions that may not materialize or that may not be accurate. This forward-looking information is subject to known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such information.

The Canadian Securities Exchange (the “CSE”) has neither approved nor disapproved the contents of this news release.

Source

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply